Can metabolomics in addition to genomics add to prognostic and predictive information in breast cancer?

Research output: Contribution to journalComment/debatepeer-review

Abstract

Genomic data from breast cancers provide additional prognostic and predictive information that is beginning to be used for patient management. The question arises whether additional information derived from other 'omic' approaches such as metabolomics can provide additional information. In an article published this month in BMC Cancer, Borgan et al. add metabolomic information to genomic measures in breast tumours and demonstrate, for the first time, that it may be possible to further define subgroups of patients which could be of value clinically.

Original languageEnglish
Article number73
JournalBMC Medicine
Volume8
DOIs
Publication statusPublished - 16 Nov 2010

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'Can metabolomics in addition to genomics add to prognostic and predictive information in breast cancer?'. Together they form a unique fingerprint.

Cite this